CD19-CAR T-cell therapy with sorafenib in post-HSCT relapse of mixed phenotype acute leukaemia (MPAL) with phenotypic myeloid to lymphoid lineage switch-A case report and review of the literature
Br J Haematol
.
2024 Sep;205(3):1215-1219.
doi: 10.1111/bjh.19608.
Epub 2024 Jun 26.
Authors
A Oszer
1
,
J Kołodrubiec
1
,
B Pawlik
1
2
,
P Marschollek
3
,
N Ćwilichowska
4
,
J Jakubowska
1
,
K Bukowska-Strakova
5
,
M Surman
5
,
J Trelińska
1
,
K Miarka-Walczyk
1
6
,
N Haze
3
,
K Liszka
3
,
M Mielcarek-Siedziuk
3
,
K Kałwak
3
,
M Poręba
4
,
A Pastorczak
1
6
,
S Janczar
1
,
W Młynarski
1
Affiliations
1
Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz, Poland.
2
Postgraduate School of Molecular Medicine, Medical University of Warsaw, Warsaw, Poland.
3
Department of Pediatric Bone Marrow Transplantation, Oncology, and Hematology, Wroclaw Medical University, Wroclaw, Poland.
4
Department of Chemical Biology and Bioimaging, Faculty of Chemistry, Wroclaw University of Science and Technology, Wroclaw, Poland.
5
Department of Clinical Immunology, Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland.
6
Department of Genetic Predisposition to Cancer, Medical University of Lodz, Lodz, Poland.
PMID:
38924036
DOI:
10.1111/bjh.19608
No abstract available
Publication types
Letter
Grants and funding
OPUS 2022/47/B/NZ5/02405/Narodowe Centrum Nauki
PRELUDIUM 2023/49/N/NZ6/02818/Narodowe Centrum Nauki
2019/ABM/01/00069/Agencja Badań Medycznych
2020/ABM/04/00002-00/Agencja Badań Medycznych